University of Leicester-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of Leicester - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013268
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Leicester (UOL) is an educational service provider that offers undergraduate, postgraduate, distance learning and part-time programs. The university offers educational and research services in various disciplines such as mathematics, biochemistry, medicine, astrophysics, genetics, biological and medical sciences, criminology, and engineering, among others. It carries out research in partnership with businesses and organizations, industry and public sector. The university operates research centers of medical humanities, landscape and climate research and bio-engineering. Its business services comprise analytical services, technology transfer and consultancy services, among others. UOL is headquartered in Leicester, the UK.

University of Leicester – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Leicester, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Leicester, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Leicester, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Leicester, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of Leicester, Medical Devices Deals, 2011 to YTD 2017 9
University of Leicester, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
University of Leicester, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Natera Enters into Agreement with Imperial College London and University of Leicester 11
MRC Technology, UCB and University of Leicester Enter into Agreement 12
GlaxoSmithKline Enters into Co-Development Agreement with University of Leicester 13
Licensing Agreements 14
AmpliPhi Enters into Licensing Agreement with University of Leicester 14
University of Leicester – Key Competitors 15
University of Leicester – Key Employees 16
University of Leicester – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Government and Public Interest 18
Nov 07, 2016: New advance in RNA studies holds out hope for cancer drug development 18
Sep 14, 2016: UK’s Largest Ever Investment Into Ground-breaking Health Research 19
May 27, 2016: University of Leicester receives funding for groundbreaking research in global health and development 20
Mar 08, 2016: New target could help to reduce symptoms of asthma attacks, research shows 21
Product News 22
Jun 16, 2017: Treatment which could prevent wound scarring to be presented at University of Leicester 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
University of Leicester, Pharmaceuticals & Healthcare, Key Facts 2
University of Leicester, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Leicester, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Leicester, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Leicester, Deals By Therapy Area, 2011 to YTD 2017 8
University of Leicester, Medical Devices Deals, 2011 to YTD 2017 9
University of Leicester, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Natera Enters into Agreement with Imperial College London and University of Leicester 11
MRC Technology, UCB and University of Leicester Enter into Agreement 12
GlaxoSmithKline Enters into Co-Development Agreement with University of Leicester 13
AmpliPhi Enters into Licensing Agreement with University of Leicester 14
University of Leicester, Key Competitors 15
University of Leicester, Key Employees 16
University of Leicester, Subsidiaries 17

★海外企業調査レポート[University of Leicester-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fukoku Mutual Life Insurance Company:企業の戦略・SWOT・財務分析
    Fukoku Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Fukoku Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Brickell Biotech Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Brickell Biotech Inc (Brickell Biotech) is a pharmaceutical company that develops differentiated therapeutics for the treatment of skin diseases. The company offers pipeline product candidates such as BBI-4000, BBI-5000, BBI-2000, BBI-3000 and BBI -6000. Its product candidate BBI-4000 is an …
  • Hester Biosciences Ltd (HESTERBIO):企業の財務・戦略的SWOT分析
    Hester Biosciences Ltd (HESTERBIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Silver Fern Farms Limited:企業の戦略的SWOT分析
    Silver Fern Farms Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Highland Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Highland Therapeutics Inc (Highland) is a pharmaceutical company that develops and commercializes novel drugs. The company utilizes delexis platform, a drug delivery technology that allows for the nighttime delivery of medicines to provide a delay in the initial release of the active drug, f …
  • Baker Hughes, a GE Co LLC (BHGE):石油・ガス:M&Aディール及び事業提携情報
    Summary Baker Hughes, a GE Co LLC (BHGE), formerly Baker Hughes Inc, a subsidiary of General Electric Co is a provider of oil and gas equipment and services. Its portfolio includes drilling equipment, subsea production systems, pipe systems, compressors, electric generators, energy recovery and stor …
  • RPC Group PLC:企業の戦略・SWOT・財務情報
    RPC Group PLC - Strategy, SWOT and Corporate Finance Report Summary RPC Group PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • CPI Aerostructures, Inc.:企業の戦略・SWOT・財務分析
    CPI Aerostructures, Inc. - Strategy, SWOT and Corporate Finance Report Summary CPI Aerostructures, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Global Marine Systems Ltd:企業の戦略的SWOT分析
    Global Marine Systems Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • The McClatchy Company (MNI):企業の財務・戦略的SWOT分析
    The McClatchy Company (MNI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • BioGaia AB (BIOG B):企業の財務・戦略的SWOT分析
    BioGaia AB (BIOG B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • National Comprehensive Cancer Network-製薬・医療分野:企業M&A・提携分析
    Summary National Comprehensive Cancer Network (NCCN) is a contract research organization that offers clinical services. The organization offers research and medical information to help patients and health professionals related to cancer care. It provides subscriptions and products which include NCCN …
  • KEPCO Plant Service & Engineering Co Ltd (051600):企業の財務・戦略的SWOT分析
    KEPCO Plant Service & Engineering Co Ltd (051600) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Oncobiologics Inc (ONS):製薬・医療:M&Aディール及び事業提携情報
    Summary Oncobiologics Inc (Oncobiologics) is a clinical stage biopharmaceutical company that identifies, develops, manufactures and commercializes biosimilar therapeutics in the areas of immunology and oncology. The company's pipeline products include ONS-3010, an adalimumab biosimilar intended for …
  • Itau Unibanco Holding SA:企業のM&A・事業提携・投資動向
    Itau Unibanco Holding SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Itau Unibanco Holding SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Taiga Building Products Ltd (TBL):企業の財務・戦略的SWOT分析
    Taiga Building Products Ltd (TBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Futura Medical Plc (FUM):製薬・医療:M&Aディール及び事業提携情報
    Summary Futura Medical Plc (Futura Medical) is a pharmaceutical company that focuses on research and development of novel products for various therapeutic areas, including sexual health and pain relief management. The company focuses on developing pharmaceutical products based on its transdermal dru …
  • Eli Lilly and Co (LLY)-製薬・医療分野:企業M&A・提携分析
    Summary Eli Lilly and Company (Lilly) is a healthcare company that discovers, develops and markets human and animal healthcare products. The company offers medicines for cardiovascular conditions, diabetes, cancer, neurological problems, critical care, men's health and musculoskeletal problems. It a …
  • Daito Trust Construction Co., Ltd.:企業の戦略・SWOT・財務分析
    Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Sellier & Bellot J.S.C.:企業の戦略・SWOT・財務分析
    Sellier & Bellot J.S.C. - Strategy, SWOT and Corporate Finance Report Summary Sellier & Bellot J.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆